Biological effects of conjugated linoleic acids supplementation
Divisions of PAS
Albers R. (2003), Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy men, Eur J Clin Nutr, 57, 595, doi.org/10.1038/sj.ejcn.1601585 ; Bassaganya-Riera J. (2010), Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in inflammatory bowel disease, Curr Opin Clin Nutr Metab Care, 13, 569, doi.org/10.1097/MCO.0b013e32833b648e ; Benito P. (2001), The effect of conjugated linoleic acid on plasma lipoproteins and tissue fatty acid composition in humans, Lipids, 36, 229, doi.org/10.1007/s11745-001-0712-x ; Beppu F. (2006), Potent inhibitory effect of trans9, trans11 isomer of conjugated linoleic acid on the growth of human colon cancer cells, J Nutr Biochem, 17, 830, doi.org/10.1016/j.jnutbio.2006.01.007 ; Bhattacharya A. (2006), Biological effects of conjugated linoleic acids in health and disease, J Nutr Biochem, 17, 789, doi.org/10.1016/j.jnutbio.2006.02.009 ; Daley C. (2010), A review of fatty acids profiles and antioxidant content in grass-fed and grain-fed beef, Nutr J, 9, 10, doi.org/10.1186/1475-2891-9-10 ; A. De La Torre (2006), Beef conjugated linoleic acid isomers reduce human cancer cell growth even when associated with other beef fatty acids, Br J Nutr, 95, 346, doi.org/10.1079/BJN20051634 ; Erickson K. (2010), Fatty acids and breast cancer: the role of stem cells, Prostaglandins Leukot Essent Fatty Acids, 82, 237, doi.org/10.1016/j.plefa.2010.02.019 ; Evans M. (2002), Isomer-specific effects of conjugated linoleic acid (CLA) on adiposity and lipid metabolism, J Nutr Biochem, 13, 508, doi.org/10.1016/S0955-2863(02)00211-5 ; French P. (2000), Fatty acid composition, including conjugated linoleic acid, of intramuscular fat from steers offered grazed grass, grass silage, or concentrate-based diets, J Anim Sci, 78, 2849. ; Gudbrandsen O. (2009), Trans-10, cis-12- conjugated linoleic acid reduces the hepatic triacylglycerol content and the leptin mRNA level in adipose tissue in obese Zucker fa/fa rats, Br J Nutr, 102, 803, doi.org/10.1017/S0007114509297200 ; Heinze V. (2012), Dietary conjugated linoleic acid and long chain n-3 fatty acids in mammary and prostate cancer protection: a review, Int J Food Sci Nutr, 63, 66, doi.org/10.3109/09637486.2011.598849 ; Hennessy A. (2011), The health promoting properties of the conjugated isomers of alpha-linolenic acid, Lipids, 46, 105, doi.org/10.1007/s11745-010-3501-5 ; Ing S. (2011), Impact of conjugated linoleic acid on bone physiology: proposed mechanism involving inhibition of adipogenesis, Nutr Rev, 69, 123, doi.org/10.1111/j.1753-4887.2011.00376.x ; Ip M. (2007), The t10, c12 isomer of conjugated linoleic acid stimulates mammary tumorigenesis in transgenic mice over-expressing erbB2 in the mammary epithelium, Carcinogenesis, 28, 1269, doi.org/10.1093/carcin/bgm018 ; Jung M. (2011), Selectively hydrogenated soybean oil exerts strong anti-prostate cancer activities, Lipids, 46, 287, doi.org/10.1007/s11745-010-3495-z ; Kelly G. (2001), Conjugated linoleic acid: a review, Altern Med Rev, 6, 367. ; Kelley N. (2007), Conjugated linoleic acid isomers and cancer, J Nutr, 137, 2599. ; Kennedy A. (2010), Antiobesity mechanisms of action of conjugated linoleic acid, J Nutr Biochem, 21, 171, doi.org/10.1016/j.jnutbio.2009.08.003 ; Koronowicz A. (2009), Effect of conjugated linoleic acid isomers on proliferation of mammary cancer cells, Roczniki Państwowego Zakładu Higieny, 60, 261. ; Kuniyasu H. (2006), Conjugated linoleic acid inhibits peritoneal metastasis in human gastrointestinal cancer cells, Int J Cancer, 118, 571, doi.org/10.1002/ijc.21368 ; Larsson S. (2009), Conjugated linoleic acid intake and breast cancer risk in a prospective cohort of Swedish women, Am J Clin Nutr, 90, 556, doi.org/10.3945/ajcn.2009.27480 ; Lin H. (1995), Survey of the conjugated linoleic acid contents of dairy products, J Dairy Sci, 78, 2358, doi.org/10.3168/jds.S0022-0302(95)76863-1 ; Masters N. (2002), Maternal supplementation with CLA decreases milk fat in humans, Lipids, 37, 133, doi.org/10.1007/s11745-002-0872-8 ; McAfee A. (2010), Red meat consumption: an overview of the risks and benefits, Meat Sci, 84, 1, doi.org/10.1016/j.meatsci.2009.08.029 ; Moon E. (2003), Anti-angiogenic activity of conjugated linoleic acid on basic fibroblast growth factor - induced angiogenesis, Oncol Rep, 10, 617. ; Moya-Camarena S. (1999), Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPAR alpha, J Lipid Res, 40, 1426. ; Oleszczuk L. (2011), Use of diet supplements, synthetic drugs and herbal remedies with immunotropic activity during pregnancy. III. Conjugated linoleic acid, Centr Eur J Immunol, 36, 308. ; O'Shea M. (2004), Immunomodulatory properties of conjugated linoleic acid, Am J Clin Nutr, 79. ; Pariza M. (2004), Perspective on the safety and effectiveness of conjugated linoleic acid, Am J Clin Nutr, 79. ; Patra A. (2011), Exploitation of dietary tannins to improve rumen metabolism and ruminant nutrition, J Sci Food Agric, 91, 24, doi.org/10.1002/jsfa.4152 ; Perdomo M. (2011), Trans-10, cis-12 conjugated linoleic acid and the PPAR-gamma agonist rosiglitazone attenuate lipopolysaccharide - induced TNF-alpha production by bovine immune cells, Domest Anim Endocrinol, 41, 118, doi.org/10.1016/j.domaniend.2011.05.005 ; J. Perfield, 2nd (2002), Effects of dietary supplementation of rumen-protected conjugated linoleic acid in dairy cows during established lactation, J Dairy Sci, 85, 2609, doi.org/10.3168/jds.S0022-0302(02)74346-4 ; Petridou A. (2003), Supplementation with CLA: isomer incorporation into serum lipids and effect on body fat of women, Lipids, 38, 805, doi.org/10.1007/s11745-003-1129-2 ; Plourde M. (2008), Conjugated linoleic acids: why the discrepancy between animal and human studies?, Nutr Rev, 66, 415, doi.org/10.1111/j.1753-4887.2008.00051.x ; Ramirez-Santana C. (2011), Enhancement of antibody synthesis in rats by feeding cis-9, trans-11 conjugated linoleic acid during early life, J Nutr Biochem, 22, 495, doi.org/10.1016/j.jnutbio.2010.04.005 ; Rastmanesh R. (2011), An urgent need to include risk-benefit analysis in clinical trials investigating conjugated linoleic acid supplements in cancer patients, Contemp Clin Trials, 32, 69, doi.org/10.1016/j.cct.2010.09.005 ; Risérus U. (2004 a), Supplementation with trans 10 cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity, Diabetologia, 47, 1016. ; Risérus U. (2004 b), Effects of cis-9, trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation, and proinflammatory markers in obese men, Am J Clin Nutr, 80, 279. ; Sakai Y. (2006), Conjugated linoleic acid reduced metastasized LL2 tumors in mouse peritoneum, Virchows Arch, 449, 341, doi.org/10.1007/s00428-006-0249-7 ; Scimeca J. (1998), Toxicological evaluation of dietary conjugated linoleic acid in male Fischer 344 rats, Food Chem Toxicol, 36, 5, 391, doi.org/10.1016/S0278-6915(97)00169-5 ; Shiraishi R. (2010), Conjugated linoleic acid suppresses colon carcinogenesis in azoxymethane-pretreated rats with long-term feeding of diet containing beef tallow, J Gastroenterol, 45, 625, doi.org/10.1007/s00535-010-0206-8 ; Sikorski A. (2008), Conjugated linoleic acid (CLA) inhibits new vessel growth in the mammalian brain, Brain Res, 1213, 35, doi.org/10.1016/j.brainres.2008.01.096 ; Silveira M. (2007), Conjugated linoleic acid (CLA) and obesity, Public Health Nutr, 10, 1181, doi.org/10.1017/S1368980007000687 ; Smedman A. (2001), Conjugated linoleic acid supplementation in humans-metabolic effects, Lipids, 36, 773, doi.org/10.1007/s11745-001-0784-7 ; Sommer E. (2002), Different effect of linoleic acid and conjugated linoleic acid on cutaneous angiogenesis induced in mice by L-1 sarcoma cells, Centr Eur J Immunol, 27, 1, 118. ; Sommer E. (2001), The effect of linoleic acid on the growth and vascularity of L-1 sarcoma in mice and on the cutaneous angiogenesis induced by tumor cells, Contemporary Oncology, 5, 250. ; Stachowska E. (2008), Conjugated dienes of linoleic acid and tumorigenesis, Ann Acad Med Stetin, 54, 122. ; Stachowska E. (2010), Conjugated linoleic acids regulate triacylglycerol and cholesterol concentrations in macrophages/foam cells by the modulation of CD36 expression, Acta Biochim Pol, 57, 379. ; Stout M. (2011), Hepatic steatosis by dietary-conjugated linoleic acid is accompanied by accumulation of diacylglycerol and increased membrane-associated protein kinase C4 in mice, Mol Nutr Food Res, 55, 1010, doi.org/10.1002/mnfr.201000413 ; Sugano M. (1998), Conjugated linoleic acid modulates tissue levels of chemical mediators and immunoglobulins in rats, Lipids, 33, 521, doi.org/10.1007/s11745-998-0236-4 ; Tanaka T. (2011), Cancer chemopreventive ability of conjugated linolenic acids, Int J Mol Sci, 12, 7495, doi.org/10.3390/ijms12117495 ; Thijs C. (2011), Fatty acids in breast milk and development of atopic eczema and allergic sensitization in infancy, Allergy, 66, 58, doi.org/10.1111/j.1398-9995.2010.02445.x ; Vyas D. (2012), Dietary conjugated linoleic acid and hepatic steatosis: species-specific effects on liver and adipose lipid metabolism and gene expression, J Nutr Metab, 2012, 932928, doi.org/10.1155/2012/932928 ; Wang Y. (2004), Dietary conjugated linoleic acid and body composition, Am J Clin Nutr, 79. ; Wiegand B. (2011), Immune response and blood chemistry of pigs fed conjugated linoleic acid, J Anim Sci, 89, 5, 1588, doi.org/10.2527/jas.2009-2722 ; Yamasaki M. (2003), Immunoglobulin and cytokine production from spleen lymphocytes is modulated in C57BL/6J mice by dietary cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid, J Nutr, 133, 784.